Kazuki Taoka1, Ayako Karakawa2, Kazuhiro Toyama1, Rie Tanaka2, Yosuke Masamoto1, Fumihiko Nitta3, Kazuichi Maruyama4, Daiju Iwata5, Satoru Kase5, Kenichi Namba5, Daigo Hashimoto6, Mineo Kurokawa1 (1.Hematol, Tokyo Univ, Tokyo, Japan, 2.Ophthalmology, Tokyo Univ., Tokyo, Japan, 3.Ophthalmology, Tohoku University, Sendai, Japan, 4.Innovative Visual Science, Osaka University, Osaka, Japan, 5.Ophthalmology, Hokkaido University, Sapporo, Japan, 6.Hematol., Hokkaido University, Sapporo, Japan)
Session information
Oral Session
Oral Session 1-14C Malignant Lymphoma: Gene Expression (1)
Fri. Oct 11, 2019 3:20 PM - 4:20 PM No.14 (Tokyo International Forum, 6F G610)
Chair: Akihiro Tomita (Department of Hematology, Fukuoka Health University School of Medicine, Japan)
Yasuhide Takeuchi1,2, Chantana Polprasert3, Nobuyuki Kakiuchi1, Kenichi Yoshida1, Masashi Sanada4, Nobuhiro Akita5, June Takeda1, Yoichi Fujii1, Hiromichi Suzuki1, Yasuhito Nanya1, Yuichi Shiraishi6, Kenichi Chiba6, Hiroko Tanaka6, Satoru Miyano6, Ponlapat Rojnuckarin3, Seishi Ogawa1,7, Hideki Makishima1 (1.Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 3.Division of Hematology, King Chulalongkorn Memorial Hospital, BKK, Thailand, 4.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 5.Department of Pediatrics, Nagoya Medical Center, Nagoya, Japan, 6.Laboratory of DNA Information Analysis, University of Tokyo, Tokyo, Japan, 7.Department of Medicine, Karolinska Institute, Stockholm, Sweden)
Yasuhito Suehara1, Mamiko Sakata-Yanagimoto1, Keiichiro Hattori1, Manabu Kusakabe1, Kota Fukumoto1, Manabu Fujisawa1, Kenichi Chiba2, Yuichi Shiraishi2, Satoru Miyano3, Seishi Ogawa4, Kosei Matsue5, Shigeru Chiba1 (1.Dept. of Hematol., Univ. of Tsukuba, Tsukuba, Japan, 2.National Cancer Center, Tokyo, Japan, 3.Laboratory of DNA Information Analysis, Human Genome Center, Tokyo, Japan, 4.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 5.Dept. of Hematol./Oncol., Kameda Medical Center, Kamogawa, Japan)
Yasuyuki Otsuka, Momoko Nishikori, Hiroshi Arima, Hepei Yuan, Akifumi Takaori (Department of Hematology and Oncology, Kyoto University)
Hiroyuki Matsui, Kotaro Shirakawa, Yoshihito Horisawa, Daniela Sarca, Hirofumi Fukuda, Yasuhiro Kazuma, Hiroyuki Yamazaki, Tadahiko Matsumoto, Akifumi Takaori (Department of Hematology and Oncology, Kyoto University, Kyoto, Japan)
Mayumi Yoshimori1,2, Shixing Wu2, Megumi Tateishi2, Ayaka Ohashi2,3, Norio Shimizu4, Kenichi Imadome5, Ayako Arai1,6 (1.Hematological Therapeutics, TMDU, Kanagawa, Japan, 2.Laboratory Molecular Genetics of Hematology, TMDU, Tokyo, Japan, 3.Immunopathology, TMDU, Tokyo, Japan, 4.Center for Stem Cell and Regenerative Medicine, TMDU, Tokyo, Japan, 5.Advanced Medicine for Infections, NCCHD, Tokyo, Japan, 6.Hematology and Oncology, St.Marianna University School of Medicine, Kanagawa, Japan)